The complexity of VAT implementation on the supply of medicines in Indonesia: What are the consequences?
DOI:
https://doi.org/10.54957/educoretax.v5i2.1386Kata Kunci:
Easy of administration, Medicines, Tax policy, VAT, VAT rateAbstrak
The policy on the imposition of Value-Added Tax (VAT) on pharmaceutical transactions in Indonesia contributes to increasing state revenue. However, this policy has not yet fully favored the public, as VAT is one of the main factors in determining drug prices, which ultimately increases the financial burden on society, especially for those suffering from various illnesses.This study aims to analyze the VAT policy on pharmaceutical transactions and identify more effective policy alternatives. The research employs a qualitative approach, utilizing in-depth interviews and literature studies as data collection techniques. The findings indicate that this policy has not fully met the principle of ease in its administrative implementation. Therefore, the proposed policy alternatives include, firstly, classifying pharmaceutical products as essential goods exempt from VAT. Secondly, implementing a multi-tiered VAT system to reduce the tax burden on pharmaceutical transactions. This study recommends simplifying the tax mechanism to ensure easier implementation for taxpayers while also prioritizing the convenience of taxpayers in fulfilling their VAT obligations related to pharmaceutical transactions.
Referensi
Abdullah, D., Anissa, M., & Dewi, N. P. (2019). Gambaran Tingkat Pengetahuan Masyarakat Tentang Obat Generik di Kecamatan Sepuluh Koto, Nagari Singgalang, Kabupaten Tanah Datar. In Health & Medical Journal (Vol. 1, Issue 2). https://doi.org/10.33854/heme.v1i2.239
Mutaqin, A. Z. (2018). GEOAREA, Vol 1.No. 1_Mei 2018. Geoarea, 1(1), 32–36.
Aryani, L., & Tambunan, M. R. U. D. (2022). Catatan Atas Formulasi Kebijakan Perubahan Tarif Pajak Pertambahan Nilai (Ppn) Di Indonesia. Dialogue : Jurnal Ilmu Administrasi Publik, 4(2), 362–381. https://doi.org/10.14710/dialogue.v4i2.14893
Beckman, S., & Smith, J. W. (2015). A Theory of Demand Based on Essential and Inessential Goods. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.2653907
Bird, R. M. . E. M. Z. (2014). Redistribution via Taxation: The Limited Role of the Personal Income Tax in Developing Countries. Annals of Economic and Finance, 15(2), 625–683.
Creese. (2011). Sales Tax on Medicine. Pharmaceutical Pricing Policies and Interventions, 1–32.
Creswell, J. W., & Creswell, J. D. (2018). Mixed Methods Procedures. In Research Defign: Qualitative, Quantitative, and Mixed M ethods Approaches.
Darussalam; Danny Septriadi; (2018). Konsep dan Studi Komparasi Pajak Pertambahan Nilai. DDTC Publishing.
Darussalam. (2021). PPN: Tarif Tunggal atau Multitarif? DDTC News.
Fanni, K. A. M. (2022). Prinsip Kesetaraan Pemungutan Pajak Pertambahan Nilai Obat-Obatan Antara Pelayanan Kesehatan Dan Perlindungan Industri Dalam Negeri. Jurnal Hukum Staatrechts, 5(2), 1–19.
Gunadi, G. (2020). A Possibility of Increasing Audit Coverage to Gain Voluntary Compliance. Jurnal Pajak Dan Bisnis (Journal of Tax and Business), 1(2 SE-Articles), 24–30. https://doi.org/10.55336/jpb.v1i2.10
Heru, Y. (2023). Perbedaan PPN Tarif Tunggal dan Multitarif. Pajak.Com.
Husna, F. U. S. (2022). Tinjauan Atas Pemanfaatan Insentif Pajak Pertambahan Nilai Masa Pandemi di KPP Pratama Pare. Jurnal Acitya Ardana, 2(2), 189–204. https://doi.org/10.31092/jaa.v2i2.1640
Indonesia, S. (2025). Farmasi Indonesia.
Irianto, H. R. E. S. (2015). Pengantar Ilmu Pajak: Kebijakan dan Implementasi di Indonesia. Rajawali Press.
Islami, V. H., Ansyori, A. K., & Helmidanora, R. (2023). Gambaran Pengadaan Obat E-Purchasing Untuk Pasien Program Rujuk Balik Di Apotek Kimia Farma Samarinda. Jurnal Riset Kefarmasian Indonesia, 5(3), 473–486. https://doi.org/10.33759/0whwam97
Kemenkes. (2023). Obat Generik dan Obat Paten.
Kemenperin, P. (2021). Membangun Kemandirian Industri Farmasi Nasional: Buku Analisis Pembangunan Industri Edisi II. Buku Analisis Pembangunan Industri, 1–38. https://www.kemenperin.go.id/download/26388/Buku-Analisis-Industri-Farmasi-2021
Kurniati, D. (2021). Wah 230 Jenis Obat-obatan Ini Kini Bebas PPN. DDTC News.
Lambojon, K., Chang, J., Saeed, A., Hayat, K., Li, P., Jiang, M., Atif, N., Desalegn, G. K., Khan, F. U., & Fang, Y. (2020). Prices, Availability and Affordability of Medicines with Value-Added Tax Exemption: A Cross-Sectional Survey in the Philippines. International Journal of Environmental Research and Public Health, 17(14). https://doi.org/10.3390/ijerph17145242
Lasok Qc, K. P. E. (2020). Nature and origins of Value Added Tax. In EU Value Added Tax Law (Vol. 89, Issue February). https://doi.org/10.4337/9781784718015.00010
Leibovici, F., & Santacreu, A. M. (2020). International Trade of Essential Goods During a Pandemic Working Paper Series International Trade of Essential Goods During a Pandemic. https://doi.org/10.20955/wp.2020.010
Lestari, E., & Puspandari, D. A. (2023). Strategi Pemerintah Desa dari Berbagai Tingkat Cakupan Peserta Menuju UHC di Kabupaten Karimun. Jurnal Jaminan Kesehatan Nasional, 3(2), 65–83. https://doi.org/10.53756/jjkn.v3i2.165
Mansury. (2002). Pajak Penghasilan Lanjutan. Penerbit YPA.
Mikaelsen, H. Z., Ulla, I. H., Karimi, D., Mathiesen, L., Viktil, K. K., Olsen Syversen, M., Nguyen, L. M., Bengtsson, K. R., Ahmed, M. V., Parker, K., Heen, A. F., Njaastad, A. M., Qazi, R., & Lea, M. (2024). Medication Discrepancies in Hospitalised Medical Patients – Status After a Decade With Targeted Medication Reconciliation Measures, a Cross-sectional Multicenter Study. Health Services Insights, 17, 11786329241254202. https://doi.org/10.1177/11786329241254202
Moon, S. (2008). Medicines as Global Public Goods: The Governance of Technological Innovation in the New Era of Global Health. Global Health Governance, II.
Mulyani, S. (2022). Pengenaan Pajak Pertambahan Nilai. Jurnal Keuangan Negara Dan Kebijakan Publik, 2(2), 205–216.
Mulyono*, P. E. (2020). Analisis Pelaksanaan Pengadaan Barang/Jasa Secara Elektronik pada Pemerintah Kabupaten Gresik. Airlangga Development Journal, 1(1), 32. https://doi.org/10.20473/adj.v1i1.18010
Notoatmodjo, S. (2008). Kesehatan dan Pembangunan Sumber Daya Manusia. Kesmas: National Public Health Journal, 2(5), 195. https://doi.org/10.21109/kesmas.v2i5.249
Nurmantu, S. (2003). Pengantar Perpajakan. Granit.
Panov, V. (2020). Value added tax on medicines in EU countries. Journal of Medical and Dental Practice, 7(2), 1227–1234. https://doi.org/10.18044/medinform.202072.1227
Pramana, P., & Chairunnisa Widya Priastuty. (2023). Perspektif Masyarakat Pengguna BPJS Kesehatan mengenai Kebijakan Kelas Rawat Inap Standar (KRIS). Jurnal Jaminan Kesehatan Nasional, 3(1), 30–41. https://doi.org/10.53756/jjkn.v3i1.98
Putranti, H. R. I. T. (2011). Teori Pajak Pertambahan Nilai, Kebijakan dan Implementasinya di Indonesia. Ghalia Indonesia.
Raharni, R., Supardi, S., & Sari, I. D. (2018). Kemandirian dan Ketersediaan Obat Era Jaminan Kesehatan Nasional (JKN): Kebijakan, Harga, dan Produksi Obat. Media Penelitian Dan Pengembangan Kesehatan, 28(4), 219–228. https://doi.org/10.22435/mpk.v28i4.269
Rahayuda, S. (2016). Identifikasi Jenis Obat Berdasarkan Gambar Logo Pada Kemasan Menggunakan Metode Naive Bayes. Klik - Kumpulan Jurnal Ilmu Komputer, 3(2), 125. https://doi.org/10.20527/klik.v3i2.46
Musgrave, R. A. & Musgrave, P. B. (1989). Public Finance in Theory and Practice. McGraw-Hill Book Company.
Saputro, C. R. A., & Fathiyah, F. (2022). Universal Health Coverage: Internalisasi Norma di Indonesia. Jurnal Jaminan Kesehatan Nasional (JJKN), 2(2), 204–216. https://doi.org/10.53756/jjkn.v2i2.108
Shenck, A.& Oldman, O. (2007). Value Added Tax : A Comparative Approach. Routledge-Cavendish.
Sugiyono. (2019). Metode Penelitian Kuantitatif, Kualitatif, dan R&D. Alphabet.
Tait, A. A. (1988). Value Added Tax: International Practice and Problems. International Monetary Fund. https://doi.org/10.5089/9781557750129.071
Thuronyi, V. (1996). Tax on Land and Buildings. Tax Law Design and Drafting, I, 264–291.
Vaughan. (1983). Guidelines for Developing A State Tax Policy. Duke Press Policy Study.
Vogler, S., Kilpatrick, K., & Babar, Z.-U.-D. (2015). Analysis of Medicine Prices in New Zealand and 16 European Countries. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 18(4), 484–492. https://doi.org/10.1016/j.jval.2015.01.003
Williams, D. (1996). Chapter 6: Value-Added Tax. Tax Law Design and Drafting, Volume 1, 1(1988), 1–66.
Wong, Z. Y., Alrasheedy, A. A., Hassali, M. A., & Saleem, F. (2017). Goods and Services Tax on Pharmaceuticals in Malaysia. Therapeutic Innovation & Regulatory Science, 51(2), 221–223. https://doi.org/10.1177/2168479016680256
World Health Organization. (2020). WHO Guideline on Country Pharmaceutical Pricing Policies, second edition. In Geneva (Vol. 2). https://www.who.int/publications/i/item/9789240011878
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2025 Farras Agung Wijaya, Maria R.U.D. Tambunan
Artikel ini berlisensi Creative Commons Attribution 4.0 International License.
